Enrique A. Conterno - Feb 14, 2022 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role: Chief Executive Officer, Director
Signature: /s/ Dorothy Pacini, Attorney-in-fact
Stock symbol: FGEN
Transactions as of: Feb 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/16/2022, 07:57 PM
Previous filing: Jan 7, 2022
Next filing: Mar 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FGEN	Common Stock	Award	$0	+179K	+135.19%	$0.00	312K	Feb 14, 2022	Direct	F1
holding	FGEN	Common Stock						27.8K	Feb 14, 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FGEN	Stock Option (Right to Buy)	Award	$0	+298K		$0.00	298K	Feb 14, 2022	Common Stock	298K	$15.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.
F2	Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.